Pharmafile Logo

Abstract Highlights from EHA 2022 : A Spotlight on CLL

- PMLiVE

Spotlight on CLL

Ahead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in CLL. Here are some of the highlights:

  1. Big interest in combining ibrutinib and venetoclax with two studies reported, both considering eradicating minimal residual disease (MRD) and how important that is:
    • Ph 3 FLAIR – interim data – at the 2-year mark when patients are discontinuing treatment, 89% of those patient’s bone marrow was MRD negative and 97% of patient’s blood was negative. This wasn’t seen with ibrutinib monotherapy, showing the strength of adding venetoclax to the combination.
    • Ph 2 CAPTIVATE with different treatment arms; some fixed duration and some driven by the endpoint. Translational data reported on the dynamics of looking at MRD, what cells are left, and do they differ – are we selecting out resistant variants? All important questions being addressed.
    • Combinations are being submitted for approval with it now being important to understand who the suitable patient is compared to the other available choices.
  2. Six-year follow-up data with venetoclax monotherapy in patients with 17p deletion – ORR approx. 77%, median OS >5yrs which is a great advantage for this patient population compared to the past, and median PFS of 28 months. Although we are moving beyond venetoclax monotherapy, this shows the level of efficacy that is being achieved.
  3. Update on the Ph 2 BRUIN study with pirtobrutinib and the patients with CLL who have had a median of 3 prior lines of therapy, meaning they are already heavily pre-treated with 86% having received a prior BTK inhibitor. Good responses are seen and now waiting to see how durable these responses are in terms of longer follow-up to see the long-term benefit.

You can also watch the full video here

About Medscape:
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...

The Power of the Pivot: How Nurse Practitioners are Closing Care Gaps for Women

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a supervisory role. But for two pioneering NPs, Laura Demuth and Jackie...

Voices of Change: Women Leading the Menopause Movement

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as something women just had to “get past” and hardly worth...

Medscape Wins Anthem Award for Rare Disease Education Platform

Platform has reached 2.4 million healthcare professionals worldwide since 2021. Newark, NJ - [November 18, 2025] - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been...

Shifting the Paradigm: A New Era for Parkinson’s Care

In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.

World Orphan Drug Congress 2025 in Amsterdam

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Game On: Medscape Education Golfs for a Cause

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...